2m 2m 2m 2m 2m 2m 2m
GUARDANT HEALTH (GH)
NASDAQ
$131.20+$2.37 (+1.84%)
Price as of Jun 23, 2026 4:41 PM EDT- $17.1BMarket Cap
- 165.36%1-Year Change
- Diagnostics & ResearchIndustry
GUARDANT HEALTH (GH)
$131.20+$2.37 (+1.84%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 982.0M +32.88% | 739.0M +31.04% | 563.9M +25.45% | 449.5M +20.31% | |
Cost of Revenue | 349.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 633.0M -14.34% | 739.0M +31.04% | 563.9M +25.45% | 449.5M +20.31% | |
Sales and Marketing Expense | 494.7M +35.55% | 364.9M +23.61% | 295.2M -1.53% | 299.8M +56.26% | |
Research and Development Expense | -364.2M +4.73% | -347.8M -5.29% | -367.2M -1.77% | -373.8M +42.01% | |
Depreciation and Amortization Expense | 39.7M -6.25% | 42.4M -1.15% | 42.9M +19.24% | 36.0M +61.47% | |
Total Operating Expenses | 1.4B +20.01% | 1.2B +4.78% | 1.1B +13.56% | 993.9M +26.67% | |
Operating Profit | -437.2M -1.43% | -443.6M -21.45% | -564.7M +3.74% | -544.4M +32.45% | |
Interest Income | 34.1M -36.50% | 53.7M +51.82% | 35.4M +482.72% | 6.1M +54.43% | |
Interest Expense | -3.9M +50.99% | -2.6M +0.12% | -2.6M +0.04% | -2.6M 0.00% | |
Interest Income and Expense and Net | 30.2M -40.92% | 51.1M +55.88% | 32.8M +838.92% | 3.5M +158.09% | |
Total Nonoperating Income and Expense | -10.5M -75.38% | -42.6M -180.12% | 53.2M +516.14% | -12.8M -150.75% | |
Income before Taxes | -417.5M -4.03% | -435.1M -9.12% | -478.8M -26.73% | -653.4M +69.96% | |
Income Taxes | -1.3M -198.36% | 1.3M +87.45% | 685,000 -39.86% | 1.1M +279.67% | |
Extraordinary Items | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -416.3M -4.61% | -436.4M -8.98% | -479.4M -26.76% | -654.6M +70.12% | |
Net Income from Continuing Operations Applicable to Common | -417.5M -4.03% | -435.1M -9.25% | -479.4M -26.76% | -654.6M +61.36% | |
Basic EPS and Net Income | -3.32 -6.74% | -3.56 -16.82% | -4.28 -33.23% | -6.41 +60.25% | |
Diluted EPS and Net Income | -3.32 -6.74% | -3.56 -16.82% | -4.28 -33.23% | -6.41 +60.25% | |
Basic Weighted Average Shares | 125.4M +2.14% | 122.7M +9.61% | 112.0M +9.60% | 102.2M +0.85% | |
Diluted Weighted Average Shares | 125.4M +2.14% | 122.7M +9.61% | 112.0M +9.60% | 102.2M +0.85% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 378.2M -28.04% | 525.5M -53.64% | 1.1B +700.25% | 141.6M -71.22% | |
Short-Term Investments | 823.4M +161.86% | 314.4M +795.91% | 35.1M -95.96% | 869.6M +97.39% | |
Cash and Cash Equivalents and Short-Term Investments | 1.2B +43.05% | 840.0M -28.12% | 1.2B +15.57% | 1.0B +8.41% | |
Total Current Assets | 1.5B +38.95% | 1.1B -21.68% | 1.3B +13.05% | 1.2B +6.95% | |
Accumulated Depreciation | 198.9M +20.16% | 165.5M +30.02% | 127.3M +44.45% | 88.1M +60.75% | |
Property and Plant and Equipment and Net | 145.9M +6.65% | 136.8M -5.71% | 145.1M -13.59% | 167.9M +34.92% | |
Total Long-Term Assets | 28.5M -23.40% | 37.2M -70.12% | 124.3M +102.32% | 61.5M +0.85% | |
Total Assets | 2.0B +35.54% | 1.5B -16.84% | 1.8B +10.96% | 1.6B -26.97% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 302.7M +34.20% | 225.6M +9.55% | 205.9M +6.57% | 193.2M -0.75% | |
Total Long-Term Debt | 1.5B +31.64% | 1.1B +0.23% | 1.1B +0.23% | 1.1B +0.23% | |
Total Long-Term Liabilities | 127.8M +37.64% | 92.8M -3.30% | 96.0M +945.93% | 9.2M +133.38% | |
Total Liabilities | 2.1B +30.01% | 1.6B -0.15% | 1.6B +5.03% | 1.5B -0.62% | |
Retained Earnings | -3.0B +16.15% | -2.6B +20.37% | -2.1B +28.84% | -1.7B +64.95% | |
Total Stockholders Equity | -99.3M -28.89% | -139.6M -188.00% | 158.7M +163.68% | 60.2M -90.67% | |
Total Shares Outstanding | 130.6M +5.36% | 124.0M +1.94% | 121.6M +18.53% | 102.6M +0.84% | |
Cash Flow | |||||
Cash from Operating Activities | -184.8M -22.97% | -239.9M -26.19% | -325.0M +5.01% | -309.5M +48.06% | |
Capital Expenditures | 48.3M +37.68% | 35.1M +71.26% | 20.5M -73.55% | 77.5M +3.23% | |
Cash from Investing Activities | -627.2M +140.02% | -261.3M -131.10% | 840.3M +460.85% | 149.8M +337.22% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 671.1M +67,482.83% | -996,000 -100.21% | 477.4M +352.46% | -189.1M +182.97% | |
Financials Ratio | |||||
Gross Margin | 64.46% N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -44.53% -25.82% | -60.02% -40.06% | -100.14% -17.31% | -121.10% +10.09% | |
Return on Assets | -23.79% -10.80% | -26.67% -5.52% | -28.23% -17.74% | -34.32% +99.64% | |
Return on Equity | 348.42% +107.60% | -4,584.47% +946.38% | -438.12% +136.00% | -185.65% +368.87% | |
Revenue Growth | 32.88% +5.92% | 31.04% +21.97% | 25.45% +25.32% | 20.31% -33.01% | |
Current Ratio | 4.84 +3.54% | 4.68 -28.50% | 6.54 +6.08% | 6.17 +7.76% | |
Cash Ratio | 1.25 -46.38% | 2.33 -57.68% | 5.50 +650.89% | 0.73 -71.00% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow